Skip to main content
Clinical Trials/NCT07380568
NCT07380568
Recruiting
Not Applicable

The Effect of Preoperative Oral Melatonin on Postoperative Pain Control After Cesarean Section: A Dose Comparison Study

Benha University1 site in 1 country60 target enrollmentStarted: October 10, 2025Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
60
Locations
1
Primary Endpoint
Postoperative pain intensity measured using the VAS (Visual Analogue Scale)

Overview

Brief Summary

The goal of this clinical trial is to learn if melatonin will decrease pain after C.S. The main questions it aims to answer are:

Does melatonin lower the number of times participants need to use a rescue analgesia? What medical problems do participants have when taking melatonin? Researchers will compare different doses of melatonin to see the ideal dose to decrease pain after C.S.

Participants will:

Take melatonin 30 min before C.S and will be observed for 24 hours for pain and consumption of other analgesia

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • \- Women aged 18-40 years.
  • Scheduled for elective cesarean section.
  • Ability to provide informed consent.

Exclusion Criteria

  • Known hypersensitivity to melatonin or opioids
  • Chronic use of analgesics, sedatives, or antidepressants.
  • History of sleep disorders or psychiatric illness.
  • Complicated pregnancies (e.g., preeclampsia, gestational diabetes).
  • Body mass index (BMI) \> 35 kg/m².
  • Emergency cesarean sections.
  • Severe systemic diseases (e.g., liver or kidney dysfunction).

Arms & Interventions

Group III: (Placebo)

Placebo Comparator

Intervention: Placebo (Drug)

Group I: (5 mg melatonin)

Active Comparator

Intervention: Melatonin 5 mg (Drug)

Group II: (10 mg melatonin)

Active Comparator

Intervention: Melatonin 10 mg (Drug)

Outcomes

Primary Outcomes

Postoperative pain intensity measured using the VAS (Visual Analogue Scale)

Time Frame: 2, 6, 12, and 24 hours post-surgery.

it typically consists of a 100 mm straight line with descriptive anchors at each end representing the extremes of the sensation (for example, "no pain" at one end and "the most severe pain imaginable" at the other). Respondents indicate their experience by marking a point on the line, and the distance from the lower anchor is measured and recorded as a continuous variable

Secondary Outcomes

  • first rescue analgesia(the first 24 hours post operative)
  • Total opioid consumption(the first 24 hours post operative)
  • Incidence of adverse effects(first 24 hours post operative)
  • Time to first ambulation post-surgery(first 24 hours post operative)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Taghreed Elshahat Sakr

lecturer of anesthesia

Benha University

Study Sites (1)

Loading locations...

Similar Trials